Ronald G Crystal
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$2.9MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $2.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 27, 2020 | NIH | STTR Phase I CNS Gene Therapy for CLN2 Disease Using Parallel Multiple Routes of Administration | $500K | LEXEO Therapeutics LLC |
| Jul 19, 2020 | NIH | STTR Phase II Oxidation-resistant Anti-protease Therapy | $342K | LEXEO Therapeutics LLC |
| Jun 16, 2020 | NIH | STTR Phase I Gene Therapy to Treat Ethanol-induced Osteoporosis Associated with Aldehyde Dehydrogenase 2 Deficiency | $252K | LEXEO Therapeutics LLC |
| Sep 23, 2019 | NIH | STTR Phase I Gene Therapy to Protect the Lung from Oxidant Stress | $225K | LEXEO Therapeutics LLC |
| May 23, 2019 | NIH | STTR Phase I Gene Therapy to Prevent Esophageal Cancer Associated with Aldehyde Dehydrogenase Deficiency | $225K | LEXEO Therapeutics LLC |
| May 20, 2019 | NIH | STTR Phase II Oxidation-resistant Anti-protease Therapy | $1.2M | LEXEO Therapeutics LLC |
| Feb 2, 2018 | NIH | STTR Phase II Oxidation-resistant Anti-protease Therapy | $225K | LEXEO Therapeutics LLC |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#640
Awards as PI#250
Patents#273
Companies
- LEXEO Therapeutics LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.